More than seven dozen members of the House of Representatives are urging the U.S. Postal Service to continue delivering medications to all Americans six days a week.
Bi-Lo on Wednesday launched in all of its pharmacies a prescription program that significantly enhances the offerings of its existing program.
Teva Pharmaceutical Industries has added a University of California at Los Angeles medical professor to its board of directors, the Israeli drug maker said.
Massachusetts and New Jersey lately have been cracking down on sterile compounding pharmacies alleged to violate safety regulations, but the crackdown may soon go nationwide, predicted a legal firm focused on the matter.
Putney has launched a generic version of a veterinary skin infection drug, the company said.
Generic drug maker Impax Labs has settled with Shire Labs over an authorized generic version of a Shire drug for treating attention deficit hyperactivity disorder, Impax said.
Mylan has appointed its president and a former partner at Goldman Sachs to its board of directors, the generic drug maker said.
For the week ended Feb. 2, influenza activity remained elevated in the United States but decreased in most areas, the Centers for Disease Control and Prevention reported Friday.
Biotech drug maker Amgen plans to launch six biosimilar drugs starting in 2017, according to published reports.
A new switch paradigm could open the door to $35.7 billion in OTC opportunity, according to a new report recently released by Francesco International.